Legend Biotech CorporationLEGNNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank43
3Y CAGR-26.8%
5Y CAGR-43.6%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-26.8%/yr
Annual compound
5Y CAGR
-43.6%/yr
Recent acceleration
Percentile
P43
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 41.48% |
| 2023 | 15.44% |
| 2022 | 16.42% |
| 2021 | 105.63% |
| 2020 | 124.60% |
| 2019 | 723.90% |
| 2018 | 180.44% |
| 2017 | 0.00% |